Search

everythinglearnresearchcommunity

for

Search:↓

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Superficial cryotherapy is effective and safe for treating alopecia areata, especially eyebrow hair loss.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Early recognition and treatment of atypical alopecia areata in infants are crucial.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

308 nm excimer light therapy may help hair regrowth in alopecia areata with delayed results and no serious side effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

DPCP is effective for treating severe alopecia areata, but relapse is common.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Latanoprost, a glaucoma treatment, was found ineffective in treating hair loss in eyebrows and eyelashes.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

PRP treatment may help with alopecia areata, especially in newer cases.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Candida antigen is an effective and promising treatment for alopecia areata.

Baricitinib improved hair loss and arthritis in a lupus patient.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.